Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension

被引：0
|
作者：
Yi Tang
Siyuan Tan
Minqi Li
Yijin Tang
Xiaoping Xu
Qinghai Zhang
Qinghua Fu
Mingxiang Tang
Jin He
Yi Zhang
Zhaofen Zheng
Jianqiang Peng
Tengteng Zhu
Wenlin Xie
机构：
[1] Hunan Normal University,Department of Cardiology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Clinical Medicine Research Center of Heart Failure of Hunan Province
[2] The First Affiliated Hospital of Hunan Normal University,Hunan Provincial People’s Hospital
[3] Hunan Normal University,Department of Gastroenterology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University
[4] Central South University,Department of Cardiovascular Medicine, The Second Xiangya Hospital
[5] The Seventh Affiliated Hospital of Sun Yat-Sen University,Department of Pathology
来源：
BMC Pulmonary Medicine | / 22卷
关键词：
Dapagliflozin; Sildenafil; Pulmonary arterial hypertension;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] EFFECTS OF GINSENOSIDES ON MONOCROTALINE-INDUCED PULMONARY ARTERIAL-HYPERTENSION IN RATS
    YANG, FX
    CHEN, X
    ASIA PACIFIC JOURNAL OF PHARMACOLOGY, 1990, 5 (04): : 305 - 310
  • [32] Astragalus Polysaccharides Attenuate Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
    Yuan, Lin-Bo
    Hua, Chun-Yan
    Gao, Sheng
    Yin, Ya-Ling
    Dai, Mao
    Meng, Han-Yan
    Li, Piao-Piao
    Yang, Zhong-Xin
    Hu, Qing-Hua
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2017, 45 (04): : 773 - 789
  • [33] Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling
    Tsai, T. H.
    Chua, S.
    Fu, M.
    Chang, L. T.
    Wu, C. J.
    Wu, C. J.
    Sheu, J. J.
    Chung, S. Y.
    Yip, H. K.
    EUROPEAN HEART JOURNAL, 2010, 31 : 81 - 82
  • [34] Sildenafil Limits Monocrotaline-Induced Pulmonary Hypertension in Rats Through Suppression of Pulmonary Vascular Remodeling
    Yen, Chia-Hung
    Leu, Steve
    Lin, Yu-Chun
    Kao, Ying-Hsien
    Chang, Li-Teh
    ChuaMd, Sarah
    Fu, Morgan
    Wu, Chiung-Jen
    Sun, Cheuk-Kwan
    Yip, Hon-Kan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (06) : 574 - 584
  • [35] Ethyl Pyruvate Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
    Liu, Chuanzhen
    Fang, Changcun
    Cao, Guangqing
    Liu, Kai
    Wang, Biao
    Wan, Zhaojie
    Li, Sijie
    Wu, Shuming
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 64 (01) : 7 - 15
  • [36] Effects of atorvastatin and losartan on monocrotaline-induced pulmonary arterial hypertension in rats
    Lin, P. S.
    Xie, H.
    Xie, L. D.
    Xu, C. S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 125 : S49 - S50
  • [37] Pathophysiological Role of Dexmedetomidine for Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
    Yamaguchi, Yohei
    Hosokawa, Susumu
    Kajikawa, Yusuke
    Maejima, Yasuhiro
    Isobe, Mitsuaki
    Furukawa, Tetsushi
    Doi, Shozaburo
    CIRCULATION, 2020, 142
  • [38] Effects of vaspin, an adipocytokine, on the progression of monocrotaline-induced pulmonary arterial hypertension
    Sakamoto, Yuzaburo
    Kameshima, Satoshi
    Okada, Muneyoshi
    Yamawaki, Hideyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S189 - S189
  • [39] Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
    Wu, Yonghui
    Cai, Changhong
    Yang, Lebing
    Xiang, Yijia
    Zhao, Huan
    Zeng, Chunlai
    MOLECULAR MEDICINE REPORTS, 2020, 21 (03) : 1192 - 1200
  • [40] Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats
    Tang, Chao
    Luo, Yunmei
    Li, Sha
    Huang, Bo
    Xu, Shangfu
    Li, Lisheng
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
12345